is the definitive guide for laboratories and manufacturers regarding the quality assurance of culture media. ANSI Webstore
Manufacturers of commercially prepared culture media must adhere to stringent manufacturing practices. Under CLSI M22-A3, they are required to:
Here is a breakdown of legitimate and legitimate-but-wary options, and what to avoid. clsi m22a3 pdf
Adhering to CLSI M22-A3 is not just a best practice; it is frequently a requirement for laboratory accreditation. Organizations such as the College of American Pathologists (CAP) and the Joint Commission align their inspection checklists with CLSI guidelines. Following this standard ensures your laboratory remains fully compliant during audits.
The most impactful contribution of CLSI M22-A3 is the categorization of culture media into two distinct groups based on historical failure rates: and Non-Exempt . 1. Exempt Media (Qualifying for Reduced QC) is the definitive guide for laboratories and manufacturers
provides essential guidelines for both manufacturers and laboratory users to ensure the reliability of ready-to-use culture media. ANSI Webstore Core Purpose and Scope
The primary goal of M22-A3 is to streamline the quality control (QC) process by identifying media with high reliability that do not require exhaustive retesting by the user. Clinical & Laboratory Standards Institute | CLSI Target Audience Adhering to CLSI M22-A3 is not just a
: It operates on the premise that retesting is redundant for media that have historically demonstrated a failure rate of Clinical & Laboratory Standards Institute | CLSI Key Features of the Third Edition